| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANTH | Anthera Pharmaceuticals Inc | THOMPSON JOHN CRAIG | President & CEO | Sep 20, 2017 | Buy | $1.32 | 8,550 | 11,286 | 19,848 | Sep 20, 2017, 07:14 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | Director | Sep 07, 2017 | Buy | $1.34 | 5,000 | 6,700 | 16,793 | Sep 07, 2017, 06:56 PM | |
| ANTH | Anthera Pharmaceuticals Inc | THOMPSON JOHN CRAIG | President & CEO | Sep 07, 2017 | Buy | $1.43 | 10,400 | 14,893 | 11,298 | Sep 07, 2017, 06:56 PM | |
| ANTH | Anthera Pharmaceuticals Inc | THOMPSON JOHN CRAIG | President & CEO | Sep 07, 2017 | Option Exercise | $1.43 | 10,400 | 14,893 | 17,590 | Sep 07, 2017, 02:43 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | Chief Executive Officer | Sep 20, 2016 | Option Exercise | $2.08 | 5,008 | 10,417 | 5,008 | Sep 22, 2016, 07:29 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Mueller Brian | Director | Dec 23, 2015 | Option Exercise | $2.89 | 10,000 | 28,900 | 10,000 | Dec 24, 2015, 12:35 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Nov 13, 2015 | Option Exercise | $3.46 | 25,000 | 86,466 | 31,647 | Nov 18, 2015, 06:53 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Oct 12, 2015 | Sale | $6.15 | 1,205 | 7,411 | 7,896 | Oct 13, 2015, 08:02 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Jun 30, 2014 | Option Exercise | $2.42 | 2,699 | 6,530 | 14,709 | Jul 01, 2014, 08:09 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Jun 30, 2013 | Option Exercise | $3.30 | 6,250 | 20,625 | 80,190 | Mar 28, 2014, 09:23 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 8,974 | 29,614 | 11,845 | Mar 28, 2014, 09:23 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LIU MAY | Chief Accounting Officer | Mar 25, 2014 | Option Exercise | $3.30 | 529 | 1,746 | 3,677 | Mar 27, 2014, 09:57 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Mar 25, 2014 | Option Exercise | $3.30 | 2,783 | 9,184 | 6,601 | Mar 27, 2014, 09:57 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 7,622 | 25,153 | 9,333 | Mar 27, 2014, 09:56 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Mar 25, 2014 | Option Exercise | $3.30 | 6,250 | 20,625 | 597,787 | Mar 27, 2014, 09:56 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Jun 30, 2013 | Option Exercise | $0.49 | 2,248 | 1,102 | 75,074 | Jul 02, 2013, 09:17 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LIU MAY | Chief Accounting Officer | Jun 30, 2013 | Option Exercise | $0.49 | 675 | 331 | 33,655 | Jul 02, 2013, 09:17 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Thompson David E. | Director | Jun 24, 2013 | Buy | $0.53 | 100,000 | 53,000 | 128,201 | Jun 26, 2013, 05:24 PM | |
| ANTH | Anthera Pharmaceuticals Inc | DZIURZYNSKI BOGDAN | Director | May 31, 2013 | Buy | $0.59 | 10,000 | 5,900 | 10,000 | Jun 04, 2013, 07:26 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | Jan 30, 2013 | Buy | $0.66 | 5,700,000 | 3,762,000 | 7,462,000 | Feb 01, 2013, 08:19 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | Jan 25, 2013 | Buy | $0.65 | 1,762,000 | 1,142,481 | 1,762,000 | Jan 29, 2013, 04:54 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Jan 03, 2013 | Option Exercise | $0.69 | 17,454 | 12,043 | 66,412 | Jan 08, 2013, 05:29 PM | |
| ANTH | Anthera Pharmaceuticals Inc | KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | Jan 03, 2013 | Option Exercise | $0.69 | 2,410 | 1,663 | 30,035 | Jan 07, 2013, 09:20 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Jan 03, 2013 | Option Exercise | $0.69 | 3,409 | 2,352 | 31,812 | Jan 07, 2013, 09:18 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Jan 03, 2013 | Option Exercise | $0.69 | 4,560 | 3,146 | 84,959 | Jan 07, 2013, 09:17 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | Jan 03, 2013 | Option Exercise | $0.69 | 8,660 | 5,975 | 41,336 | Jan 07, 2013, 09:17 PM | |
| ANTH | Anthera Pharmaceuticals Inc | KILFOIL GEORGINA | SVP,Product Dev.& Project Mgmt | Jun 30, 2012 | Option Exercise | $0.69 | 2,068 | 1,427 | 24,601 | Jul 03, 2012, 07:27 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Jun 30, 2012 | Option Exercise | $0.69 | 1,838 | 1,268 | 24,821 | Jul 03, 2012, 07:27 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | Jun 29, 2012 | Sale | $0.73 | 1,283,300 | 942,071 | 0 | Jul 03, 2012, 03:19 PM | |
| ANTH | Anthera Pharmaceuticals Inc | HENNEY CHRISTOPHER S | Director | Jun 29, 2012 | Buy | $0.75 | 100,000 | 74,930 | 100,000 | Jul 02, 2012, 05:46 PM | |
| ANTH | Anthera Pharmaceuticals Inc | HENNEY CHRISTOPHER S | Director | Jun 29, 2012 | Buy | $0.75 | 100,000 | 74,930 | 202,429 | Jul 02, 2012, 05:46 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Jun 29, 2012 | Buy | $0.76 | 20,000 | 15,200 | 645,125 | Jul 02, 2012, 03:53 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | Mar 20, 2012 | Sale | $2.90 | 116,800 | 338,638 | 2,715,000 | Mar 22, 2012, 06:15 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | Mar 21, 2012 | Sale | $2.87 | 125,000 | 358,312 | 2,590,000 | Mar 22, 2012, 06:15 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | Mar 22, 2012 | Sale | $2.40 | 1,306,700 | 3,140,131 | 1,283,300 | Mar 22, 2012, 06:15 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Mar 01, 2012 | Sale | $6.57 | 2,000 | 13,140 | 26,659 | Mar 05, 2012, 04:01 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Feb 23, 2012 | Option Exercise | $0.26 | 40,000 | 10,400 | 79,519 | Feb 27, 2012, 05:26 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and C.E.O. | Feb 15, 2012 | Sale | $7.84 | 15,000 | 117,600 | 625,125 | Feb 17, 2012, 05:15 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Feb 03, 2012 | Sale | $8.20 | 30,000 | 246,000 | 27,967 | Feb 06, 2012, 08:04 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | C.F.O. and C.B.O. | Feb 01, 2012 | Sale | $7.66 | 15,000 | 114,900 | 31,151 | Feb 03, 2012, 04:01 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Feb 01, 2012 | Sale | $7.67 | 2,000 | 15,340 | 21,241 | Feb 03, 2012, 04:01 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and C.E.O. | Jan 31, 2012 | Option Exercise | $0.26 | 20,000 | 5,200 | 640,125 | Feb 02, 2012, 07:37 PM | |
| ANTH | Anthera Pharmaceuticals Inc | HEALY JAMES | Director | Jan 28, 2012 | Option Exercise | $4.19 | 12,000 | 50,280 | 32,443 | Jan 31, 2012, 05:53 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and Chief Executive | Jan 17, 2012 | Sale | $6.75 | 15,000 | 101,250 | 627,125 | Jan 19, 2012, 05:03 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Jan 10, 2012 | Sale | $6.51 | 800 | 5,205 | 23,241 | Jan 12, 2012, 12:58 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | Chief Technology Officer | Jan 06, 2012 | Sale | $6.50 | 1,200 | 7,800 | 24,441 | Jan 10, 2012, 02:27 PM | |
| ANTH | Anthera Pharmaceuticals Inc | HEALY JAMES | Director | Dec 30, 2011 | Sale | $6.22 | 25,000 | 155,625 | 3,298,684 | Jan 03, 2012, 08:31 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Buatois Eric | 10% Owner | Dec 30, 2011 | Sale | $6.22 | 25,000 | 155,625 | 3,298,684 | Jan 03, 2012, 08:31 PM | |
| ANTH | Anthera Pharmaceuticals Inc | HEALY JAMES | Director | Dec 22, 2011 | Sale | $6.22 | 25,000 | 155,605 | 3,319,314 | Dec 23, 2011, 06:22 PM | |
| ANTH | Anthera Pharmaceuticals Inc | HEALY JAMES | Director | Dec 21, 2011 | Sale | $6.51 | 25,000 | 162,770 | 3,339,944 | Dec 23, 2011, 06:22 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Azan Alain | 10% Owner | Dec 21, 2011 | Sale | $6.51 | 25,000 | 162,770 | 3,339,944 | Dec 23, 2011, 06:22 PM | |
| ANTH | Anthera Pharmaceuticals Inc | SOFINNOVA VENTURE PARTNERS VI L P | 10% Owner | Dec 22, 2011 | Sale | $6.22 | 25,000 | 155,605 | 3,319,314 | Dec 23, 2011, 06:22 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Azan Alain | 10% Owner | Mar 04, 2010 | Option Exercise | $6.30 | 1,994,850 | 12,560,454 | 3,360,574 | Dec 22, 2011, 06:24 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Dec 15, 2011 | Sale | $6.34 | 15,000 | 95,065 | 642,125 | Dec 16, 2011, 09:53 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | Dec 09, 2011 | Sale | $6.75 | 40,000 | 270,000 | 2,848,000 | Dec 13, 2011, 06:37 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | Dec 13, 2011 | Sale | $6.50 | 16,200 | 105,300 | 2,831,800 | Dec 13, 2011, 06:37 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | Nov 16, 2011 | Sale | $6.87 | 75,000 | 515,250 | 2,915,000 | Nov 18, 2011, 05:57 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | Nov 17, 2011 | Sale | $6.67 | 72,000 | 480,240 | 2,891,000 | Nov 18, 2011, 05:57 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | Nov 18, 2011 | Sale | $6.50 | 9,000 | 58,500 | 2,888,000 | Nov 18, 2011, 05:57 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Nov 15, 2011 | Sale | $6.96 | 30,000 | 208,704 | 672,125 | Nov 17, 2011, 04:01 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | Nov 11, 2011 | Sale | $7.14 | 5,000 | 35,700 | 2,995,000 | Nov 15, 2011, 06:29 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | Nov 14, 2011 | Sale | $6.95 | 5,000 | 34,750 | 2,990,000 | Nov 15, 2011, 06:29 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | Nov 15, 2011 | Sale | $6.93 | 50,000 | 346,500 | 2,940,000 | Nov 15, 2011, 06:29 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Nov 08, 2011 | Option Exercise | $3.50 | 30,000 | 105,063 | 72,967 | Nov 10, 2011, 05:06 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Nov 03, 2011 | Sale | $6.88 | 15,000 | 103,236 | 46,151 | Nov 04, 2011, 08:24 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Oct 25, 2011 | Sale | $7.07 | 4,637 | 32,784 | 0 | Oct 27, 2011, 07:48 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Oct 21, 2011 | Sale | $6.25 | 23,235 | 145,219 | 649,004 | Oct 25, 2011, 09:55 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Oct 18, 2011 | Sale | $6.25 | 6,745 | 42,156 | 660,360 | Oct 20, 2011, 09:28 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 08, 2011 | Option Exercise | $1.34 | 10,000 | 13,400 | 61,151 | Aug 09, 2011, 06:21 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Aug 08, 2011 | Option Exercise | $0.26 | 50,000 | 13,000 | 90,512 | Aug 09, 2011, 06:16 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 02, 2011 | Sale | $7.31 | 5,000 | 36,571 | 4,937 | Aug 04, 2011, 08:08 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Aug 03, 2011 | Sale | $6.88 | 14,600 | 100,432 | 51,151 | Aug 04, 2011, 08:08 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Jul 15, 2011 | Sale | $7.95 | 15,000 | 119,258 | 667,125 | Jul 18, 2011, 05:40 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Jul 12, 2011 | Option Exercise | $0.26 | 15,000 | 3,900 | 57,967 | Jul 14, 2011, 04:15 PM | |
| ANTH | Anthera Pharmaceuticals Inc | VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP | 10% Owner | Jul 07, 2011 | Option Exercise | $2.42 | 19,563 | 47,264 | 5,357,528 | Jul 11, 2011, 05:49 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Jun 30, 2011 | Option Exercise | $8.17 | 48,500 | 396,245 | 40,512 | Jul 05, 2011, 06:37 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Jun 30, 2011 | Option Exercise | $8.17 | 23,500 | 191,995 | 65,751 | Jul 05, 2011, 06:34 PM | |
| ANTH | Anthera Pharmaceuticals Inc | KILFOIL GEORGINA | SVP, Prod. Dev. & Project Mngm | Jun 30, 2011 | Option Exercise | $8.17 | 5,625 | 45,956 | 16,875 | Jul 05, 2011, 06:31 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Jun 30, 2011 | Option Exercise | $8.17 | 17,500 | 142,975 | 42,967 | Jul 05, 2011, 06:28 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ODINK DEBRA | VP, Pharmaceutical R&D | Jun 30, 2011 | Option Exercise | $8.17 | 3,670 | 29,984 | 25,641 | Jul 05, 2011, 06:23 PM | |
| ANTH | Anthera Pharmaceuticals Inc | Hislop Colin | Chief Medical Officer | Jun 29, 2011 | Option Exercise | $0.26 | 10,000 | 2,600 | 60,062 | Jun 30, 2011, 08:06 PM | |
| ANTH | Anthera Pharmaceuticals Inc | LOWE CHRISTOPHER P. | Chief Financial Officer & CBO | Jun 21, 2011 | Option Exercise | $1.31 | 20,000 | 26,200 | 87,645 | Jun 22, 2011, 08:11 PM | |
| ANTH | Anthera Pharmaceuticals Inc | VANTAGEPOINT VENTURE ASSOCIATES IV LLC | 10% Owner | Jun 16, 2011 | Sale | $8.67 | 15,500 | 134,385 | 4,836,202 | Jun 20, 2011, 05:46 PM | |
| ANTH | Anthera Pharmaceuticals Inc | TRUEX PAUL F | President and CEO | Jun 15, 2011 | Sale | $8.30 | 15,000 | 124,539 | 682,125 | Jun 17, 2011, 07:50 PM | |
| ANTH | Anthera Pharmaceuticals Inc | VANTAGEPOINT VENTURE PARTNERS IV Q LP | 10% Owner | Jun 13, 2011 | Sale | $8.80 | 1,300 | 11,440 | 4,839,645 | Jun 15, 2011, 08:21 PM | |
| ANTH | Anthera Pharmaceuticals Inc | VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP | 10% Owner | Jun 14, 2011 | Sale | $8.81 | 699 | 6,158 | 4,839,011 | Jun 15, 2011, 08:21 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | Jun 09, 2011 | Sale | $8.11 | 37,000 | 300,070 | 3,030,000 | Jun 10, 2011, 06:28 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | Jun 10, 2011 | Sale | $8.18 | 30,000 | 245,400 | 3,000,000 | Jun 10, 2011, 06:28 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | Jun 08, 2011 | Sale | $8.02 | 33,000 | 264,660 | 3,067,000 | Jun 10, 2011, 06:28 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | May 16, 2011 | Sale | $7.20 | 12,000 | 86,400 | 3,308,334 | Jun 06, 2011, 06:19 AM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | May 17, 2011 | Sale | $8.32 | 100,000 | 832,000 | 3,208,334 | Jun 06, 2011, 06:19 AM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | May 18, 2011 | Sale | $8.03 | 69,334 | 556,752 | 3,139,000 | Jun 06, 2011, 06:19 AM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | May 11, 2011 | Sale | $7.22 | 13,000 | 93,860 | 3,320,334 | Jun 06, 2011, 06:16 AM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | May 09, 2011 | Sale | $7.26 | 10,000 | 72,600 | 3,439,734 | Jun 06, 2011, 06:16 AM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | May 10, 2011 | Sale | $7.23 | 106,400 | 769,272 | 3,333,334 | Jun 06, 2011, 06:16 AM | |
| ANTH | Anthera Pharmaceuticals Inc | VANTAGEPOINT VENTURE PARTNERS IV LP | 10% Owner | May 26, 2011 | Sale | $8.60 | 4,800 | 41,280 | 4,840,823 | May 31, 2011, 07:31 PM | |
| ANTH | Anthera Pharmaceuticals Inc | OrbiMed Capital GP IV LLC | Director | May 25, 2011 | Sale | $8.65 | 4,800 | 41,520 | 3,134,200 | May 27, 2011, 06:58 PM | |
| ANTH | Anthera Pharmaceuticals Inc | ISALY SAMUEL D | Director | May 26, 2011 | Sale | $8.53 | 34,200 | 291,726 | 3,100,000 | May 27, 2011, 06:58 PM | |
| ANTH | Anthera Pharmaceuticals Inc | VANTAGEPOINT VENTURE PARTNERS IV LP | 10% Owner | May 23, 2011 | Sale | $8.18 | 26,703 | 218,431 | 4,922,134 | May 25, 2011, 06:42 PM | |
| ANTH | Anthera Pharmaceuticals Inc | VANTAGEPOINT VENTURE PARTNERS IV LP | 10% Owner | May 24, 2011 | Sale | $8.42 | 52,196 | 439,490 | 4,874,844 | May 25, 2011, 06:42 PM |
Menu